Literature DB >> 26371256

A Distinctive Cytoplasmic Tail Contributes to Low Surface Expression and Intracellular Retention of the Patr-AL MHC Class I Molecule.

Ana Goyos1, Lisbeth A Guethlein2, Amir Horowitz1, Hugo G Hilton2, Michael Gleimer1, Frances M Brodsky3, Peter Parham4.   

Abstract

Chimpanzees have orthologs of the six fixed, functional human MHC class I genes. But, in addition, the chimpanzee has a seventh functional gene, Patr-AL, which is not polymorphic but contributes substantially to population diversity by its presence on only 50% of MHC haplotypes. The ancestral AL gene emerged long before the separation of human and chimpanzee ancestors and then subsequently and specifically lost function during human evolution, but was maintained in chimpanzees. Patr-AL is an alloantigen that participates in negative and positive selection of the T cell repertoire. The three-dimensional structure and the peptide-binding repertoire of Patr-AL and HLA-A*02 are surprisingly similar. In contrast, the expression of these two molecules is very different, as shown using specific mAbs and polyclonal Abs made against Patr-AL. Peripheral blood cells and B cell lines express low levels of Patr-AL at the cell surface. Higher levels are seen for 221-cell transfectants expressing Patr-AL, but in these cells a large majority of Patr-AL molecules are retained in the early compartments of the secretory pathway: mainly the endoplasmic reticulum, but also cis-Golgi. Replacing the cytoplasmic tail of Patr-AL with that of HLA-A*02 increased the cell-surface expression of Patr-AL substantially. Four substitutions distinguish the Patr-AL and HLA-A*02 cytoplasmic tails. Systematic mutagenesis showed that each substitution contributes changes in cell-surface expression. The combination of residues present in Patr-AL appears unique, but each individual residue is present in other primate MHC class I molecules, notably MHC-E, the most ancient of the functional human MHC class I molecules.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26371256      PMCID: PMC4592827          DOI: 10.4049/jimmunol.1500397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.

Authors:  N Rouas-Freiss; R M Gonçalves; C Menier; J Dausset; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation.

Authors:  Gregory Lizée; Genc Basha; Wilfred A Jefferies
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

Review 4.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

5.  Empty MHC class I molecules come out in the cold.

Authors:  H G Ljunggren; N J Stam; C Ohlén; J J Neefjes; P Höglund; M T Heemels; J Bastin; T N Schumacher; A Townsend; K Kärre
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

6.  A class I antigen, HLA-G, expressed in human trophoblasts.

Authors:  S Kovats; E K Main; C Librach; M Stubblebine; S J Fisher; R DeMars
Journal:  Science       Date:  1990-04-13       Impact factor: 47.728

7.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

Authors:  N Lee; M Llano; M Carretero; A Ishitani; F Navarro; M López-Botet; D E Geraghty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

8.  HIV-1 Nef disrupts antigen presentation early in the secretory pathway.

Authors:  Matthew R Kasper; Jeremiah F Roeth; Maya Williams; Tracey M Filzen; Rebekah I Fleis; Kathleen L Collins
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

9.  Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.

Authors:  G Ferrari; A M Knight; C Watts; J Pieters
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

10.  HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail.

Authors:  Jeremiah F Roeth; Maya Williams; Matthew R Kasper; Tracey M Filzen; Kathleen L Collins
Journal:  J Cell Biol       Date:  2004-11-29       Impact factor: 10.539

View more
  4 in total

Review 1.  AIDS in chimpanzees: the role of MHC genes.

Authors:  Natasja G de Groot; Corinne M C Heijmans; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

2.  Gorilla MHC class I gene and sequence variation in a comparative context.

Authors:  Jörg B Hans; Richard A Bergl; Linda Vigilant
Journal:  Immunogenetics       Date:  2017-03-22       Impact factor: 2.846

3.  Reduced bonobo MHC class I diversity predicts a reduced viral peptide binding ability compared to chimpanzees.

Authors:  Vincent Maibach; Linda Vigilant
Journal:  BMC Evol Biol       Date:  2019-01-10       Impact factor: 3.260

Review 4.  Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC.

Authors:  Emily E Wroblewski; Peter Parham; Lisbeth A Guethlein
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.